Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Expression of Sialyl-Tn in breast cancer - Correlation with prognostic parameters
Publication

Publications

Expression of Sialyl-Tn in breast cancer - Correlation with prognostic parameters

Title
Expression of Sialyl-Tn in breast cancer - Correlation with prognostic parameters
Type
Article in International Scientific Journal
Year
1996
Authors
soares, r
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
marinho, a
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
schmitt, f
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 192
Pages: 1181-1186
ISSN: 0344-0338
Publisher: Elsevier
Other information
Authenticus ID: P-001-DBA
Abstract (EN): To investigate the expression of a simple mucin-type carbohydrate antigen (Sialyl-Tn/STn) and its putative relationship with established or potentially useful clinico-pathologic prognostic parameters in breast cancer, we studied forty-six cases of invasive breast carcinoma in formalin-fixed, paraffin-embedded tissue sections. STn antigen was detected by the HB-STn antibody using an avidin-biotin-peroxidase method. The parameters studied were tumour size, histologic grade, nodal status, proliferative index (with MIB-1), ER expression, ploidy, c-erbB-2 and p53 expression. STn expression was observed in 18 cases (39%) of breast cancer The expression of STn was associated with axillary node metastasis, ER negativity and c-erbB-2 expression. A tendency towards an association between STn immunoreactivity and high histologic grade was also found. No correlation was observed between STn immunoreactivity and age, tumour size, proliferative index, ploidy and p53 expression. We conclude that the detection of STn immunoreactivity may be useful for predicting the likelihood of lymph node metastasis and that the outcome of patients with breast cancer should be further investigated in order to find whether or not the data of the present study are confirmed in larger series.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Angiogenesis in breast cancer is related to age but not to other prognostic parameters (1997)
Article in International Scientific Journal
marinho, a; soares, r; ferro, j; lacerda, m; schmitt, fc

Of the same journal

UNUSUAL BONY LESIONS OF HISTIOCYTOSIS-X IN A PATIENT PREVIOUSLY TREATED FOR HODGKINS-DISEASE - LETTER TO THE CASE (1990)
Another Publication in an International Scientific Journal
SAMBADE, C; Sobrinho Simoes, M
Unusual bony lesions of histiocytosis X in a patient previously treated for Hodgkin's disease: Comment (1990)
Another Publication in an International Scientific Journal
Sambade, C; Sobrinho Simoes, M
Synovial sarcoma: Immunohistochemical expression of P-glycoprotein and glutathione S transferase-pi and clinical drug resistance (1997)
Another Publication in an International Scientific Journal
Lopes, JM; Bruland, OS; Bjerkehagen, B; Silva, MC; Holm, R; Pettersen, EO; Solheim, OP; SobrinhoSimoes, M; Nesland, JM
Spiradenoma associated with apocrine adenoma component - Critical commentary (1996)
Another Publication in an International Scientific Journal
Lopes, JM
Solitary fibrous tumor of the pleura: Letter to the case II (1991)
Another Publication in an International Scientific Journal
David L; Sobrinho Simoes, M

See all (70)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-15 at 07:59:56 | Privacy Policy | Personal Data Protection Policy | Whistleblowing